Short Interest in Biofrontera Inc. (NASDAQ:BFRIW) Decreases By 60.0%

Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) was the recipient of a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 2,578 shares, a decline of 60.0% from the July 15th total of 6,447 shares. Based on an average daily volume of 5,485 shares, the short-interest ratio is currently 0.5 days.

Biofrontera Stock Up 6.9%

NASDAQ:BFRIW opened at $0.02 on Friday. Biofrontera has a 52 week low of $0.02 and a 52 week high of $0.19. The firm’s fifty day moving average is $0.03 and its 200-day moving average is $0.04.

Biofrontera Company Profile

(Get Free Report)

Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.

The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.

Featured Stories

• Five stocks we like better than Biofrontera
• Asian Market Circuit Breakers Hit Stocks, Not AI Demand
• Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
• Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
• Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal